Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2010 February;101(1) > Minerva Medica 2010 February;101(1):9-23

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

 

Minerva Medica 2010 February;101(1):9-23

THROMBOSIS FORUM 

    ORIGINAL ARTICLES

Drug-eluting stents: limitations of early generation and progress with newer generation devices

Khattab A. A., Windecker S.

Department of Cardiology, Bern University Hospital, Bern, Switzerland

The success of first generation drug-eluting stents, namely by reducing restenosis and the need of repeat revascularization procedures is hampered by some limitations affecting device safety. Intense research efforts helped to identify these shortcomings and direct research to develop newer generation drug-eluting stents with the potential to circumvent these drawbacks. This review will discuss limitations of early generation drug-eluting stents, focus on solutions provided by newer generation devices, and shed light on unresolved issues and potential future solutions.

language: English


FULL TEXT  REPRINTS

top of page